CCO Interactive Case Challenges

Diagnosis and Treatment of Cutaneous T-Cell Lymphoma

Interactive Case Challenges

A 65-Year-Old Male With Stage IB Mycosis Fungoides

Faculty:

John A. Zic, MD headshot
  • John A. Zic, MD

CME CREDIT INFORMATION

Release Date: 07/21/06

Expiration Date: 07/20/07


Physicians: maximum of 0.75 AMA PRA Category 1 Credit(s)

Status: Please log in to view status



Along with John Zic, MD, investigate the diagnosis of mycosis fungoides and review the treatment options available in both treatment-naïve and previously treated patients.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the elements of a diagnosis of the major CTCL variant mycosis fungoides
  • Discuss the treatment modalities available for patients with mycosis fungoides, in both the first-line and relapsed/refractory settings
  • Review strategies for long-term treatment for patients with mycosis fungoides, including the management of treatment-emergent adverse events

Treatment of a 51-Year-Old Female Patient With Newly Diagnosed Cutaneous T-Cell Lymphoma

Faculty:

Andrew J. Lipman, MD headshot
  • Andrew J. Lipman, MD

CME CREDIT INFORMATION

Release Date: 08/09/06

Expiration Date: 08/08/07


Physicians: maximum of 0.75 AMA PRA Category 1 Credit(s)

Status: Please log in to view status



Along with Andrew J. Lipman, MD, participate in the management of a patient newly diagnosed with CTCL, including of the selection of proper staging techniques, the approach to patients with progressive disease, and the use of skin-directed or systemic treatments.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe proper staging techniques for patients newly diagnosed with CTCL
  • Discuss the skin-directed and systemic therapies available for the treatment of patients with CTCL
  • Review strategies for managing CTCL patients who progress or experienced therapy-related adverse events after treatment with skin-directed or systemic therapies

A 75-Year-Old Male With Early Sézary Syndrome

Faculty:

David J. Straus, MD headshot
  • David J. Straus, MD

CME CREDIT INFORMATION

Release Date: 09/06/06

Expiration Date: 09/05/07


Physicians: maximum of 0.75 AMA PRA Category 1 Credit(s)

Status: Please log in to view status



Along with David J. Straus, MD, review the diagnosis and treatment of an older patient with Sézary syndrome, including the use of combination therapy and the management of treatment-emergent adverse events.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe proper diagnostic and staging techniques for patients with Sézary syndrome
  • Discuss the available first- and second-line therapies for the treatment of patients with Sézary syndrome
  • Review the strategies for augmenting response and managing adverse events, including the use of combination therapy and pharmacologic intervention, during the course of treatment for Sézary syndrome
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.